Add 2 More Reports For 20% off

Report Overview

The substance drug abuse market was valued at USD 7.67 Billion in 2023, driven by the rising incidence of substance abuse across the 8 major markets. The market is expected to grow at a CAGR of 5.10% during the forecast period of 2024-2032, with the values likely to reach USD 12.00 Billion by 2032.

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

  • The market for substance drug abuse is driven by the rising incidences of substance abuse, propelled by stress and anxiety, peer pressure, and mental health issues among the general public.
  • The rising introduction of grant fund opportunities directed at promoting the development of solutions that enhance the treatment, diagnosis, or monitoring of people affected by substance use disorder and addiction is expected to boost market growth in the coming years.
  • The increasing use of mobile health apps to manage drug addiction issues is a significant market trend.

Substance Drug Abuse Market Overview

Substance abuse or drug abuse refers to the excessive use of psychoactive drugs like pain medications, alcohol, or illegal drugs which can result in emotional, physical, and social harm to an individual. Alcohol is reported as the most commonly used drug by Americans, followed by tobacco and marijuana. In the United States, 1 in 4 people over the age of 12 admitted to the use of illicit drugs. The market for substance drug abuse is driven by the rising incidences of substance abuse, propelled by stress and anxiety, peer pressure, and mental health issues among the general public. The rise in government policies and initiatives that work towards reducing drug abuse and raising awareness about the dangers of addiction are expected to fuel market growth. Moreover, the expansion of treatment options, growth in telemedicine services, and the increasing adoption of digital health technologies are anticipated to shape the market dynamics.

Substance Drug Abuse Market Growth Drivers

Increasing Incidence of Substance Abuse is Driving Market Growth

Drug and substance abuse poses a major problem in the United States. According to the recent National Survey on Drug Use, 70 million Americans accounting for 25% of the population admitted to using illicit drugs such as cocaine, heroin, and methamphetamines. The survey also revealed that 48.7 million individuals in the United States struggle with substance abuse. The rising incidence of substance abuse, driven by factors such as stress, peer pressure, and mental health issues, is contributing to the market growth.

Substance Drug Abuse Market Trends

Substance Drug Abuse Market Segmentation

The market report offers a detailed analysis of the market based on the following segments:

Market Breakup by Treatment Type

  • Drugs
    • Methadone
    • Buprenorphine
    • Naltrexone
    • Others
  • Counselling & Behavioral Therapy
  • Others

Market Breakup by Route of Administration

  • Oral
  • Parenteral
  • Others

Market Breakup by End User

  • Hospitals & Clinics
  • Rehabilitation Centers
  • Homecare Settings
  • Others

Market Breakup by Region

  • United States
  • EU-4 and the United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
  • Japan
  • India

Substance Drug Abuse Market Share

Treatment Segment is Anticipated to Witness Substantial Growth

The market segmentation based on treatment includes drugs (methadone, buprenorphine, naltrexone, and others), as well as counseling and behavioral therapy, among others. The drug segment helps in managing withdrawal symptoms and cravings. Methadone is commonly used to treat opioid addiction and is also included in government-supported treatment programs due to its established efficacy. Counseling and behavioral therapies also play a significant role in addiction treatment. The growing demand for virtual counseling services, particularly through telehealth platforms, is poised to aid the growth of the treatment segment in the forecast period.

Substance Drug Abuse Market Analysis by Region

The market segmentation by region includes the United States, EU-4 (Germany, France, Italy, Spain), the United Kingdom, Japan, and India. The United States dominates the market share owing to the increased legalization of cannabis and the growing public awareness about mental health issues. Increased government initiatives such as the establishment of the Substance Abuse and Mental Health Services Administration (SAMHSA), an agency that operates within the U.S. Department of Health and Human Services, work towards enhancing behavioral health in the country including services that improve the accessibility of substance use and mental disorder information. Additionally, the expansion of telehealth services and the rising emphasis on prescription drug abuse are likely to support the market growth.

Leading Players in the Substance Drug Abuse Market

The key features of the market report comprise patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, and strategic initiatives by the leading key players. The major companies in the market are as follows:

Pfizer Inc.

Pfizer, headquartered in New York, United States, plays a significant role in the growth of the market. Pfizer manufactures Naloxone Hydrochloride Injection, USP, a pure opioid antagonist that can prevent or reverse the effects of opioids such as sedation, hypotension, and respiratory depression.

Mallinckrodt Pharmaceuticals

Mallinckrodt Pharmaceuticals, based in Staines-upon-Thames, United Kingdom, is a leading manufacturer of gener...

Rosemont Pharmaceuticals Limited

United Kingdom-based Rosemont Pharmaceuticals has a prominent presence in the market, known for its novel-deli...

Spectrum Chemicals

Spectrum Chemical is one of the leading players in the market, recognized as a global provider of quality chem...

*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*

Other key players in the market include Taj Pharmaceuticals Limited, VistaPharm LLC, Teva Pharmaceuticals Inc., Hikma Pharmaceutical PLC, Braeburn Inc., and Atlas Medical GmbH.

Key Questions Answered in the Substance Drug Abuse Market Report

  • What was the substance drug abuse market value in 2023?
  • What is the substance drug abuse market forecast outlook for 2024-2032?
  • What are the regional markets covered in the EMR report?
  • What is market segmentation based on treatment?
  • What is the market breakup based on the route of administration?
  • Who are the major end users in the market?
  • What is the market breakup by distribution channels?
  • What are the major factors aiding the substance drug abuse market demand?
  • How has the market performed so far and how is it anticipated to perform in the coming years?
  • What are the market's major drivers, opportunities, and restraints?
  • Which regional market is expected to lead the market share in the forecast period?
  • Which country is expected to experience expedited growth during the forecast period?
  • How does the rising burden of substance abuse disorders affect the market landscape?
  • What are the major substance drug abuse market trends?
  • How does the growing awareness about substance abuse impact the market size?
  • Which treatment will dominate the market share?
  • Which route of administration is expected to have a high market value in the coming years?
  • Which end user will experience the highest demand in the market segment?
  • Which distribution channel is projected to contribute to the highest market growth?
  • Who are the key players involved in the substance drug abuse market?
  • What is the patent landscape of the market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers and acquisitions among the key market players shaping the market dynamics?

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Treatment Type
  • Route of Administration
  • End User
  • Region
Breakup by Treatment Type
  • Drugs
  • Counselling & Behavioral Therapy
  • Others
Breakup by Route of Administration
  • Oral
  • Parenteral
  • Others
Breakup by End User
  • Hospitals & Clinics
  • Rehabilitation Centers
  • Homecare Settings
  • Others
Breakup by Region
  • United States
  • EU-4 and the United Kingdom
  • Japan
  • India
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • PESTEL Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Company News and Developments
    • Certifications
Companies Covered
  • Pfizer Inc.
  • Mallinckrodt Pharmaceuticals
  • Rosemont Pharmaceuticals Limited
  • Spectrum Chemicals
  • Taj Pharmaceuticals Limited
  • VistaPharm LLC
  • Teva Pharmaceuticals Inc.
  • Hikma Pharmaceutical PLC
  • Atlas Medical GmbH
  • Braeburn Inc.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,499

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,699

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,599

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,599

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124